13F-HR filed by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P. filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-14, with 25 holding rows worth $1,862,830,000.
- Accession
- 0001144204-19-040093
- Filer
- CIK 1346824
- Filed
- 2019-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2019
A holdings report, 25 entries on the cover page, a total value of $1,862,830,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,862,830,000 with VALUE read as thousands by filing date, 13F file number 028-12884. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 4,132,442 | $475,851,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 7,775,207 | $202,855,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 3,722,504 | $177,861,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 4,858,260 | $136,959,000 | thousands by filing date | |
| SYNTHORX INC COM | 87167A103 | Stock | 9,724,598 | $131,379,000 | thousands by filing date | |
| EIDOS THERAPEUTICS INC. | 28249H104 | Common Stock | 2,162,671 | $112,726,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 5,108,330 | $71,466,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 6,880,323 | $59,515,000 | thousands by filing date | |
| MYOVANT SCIENCES LTD | G637AM102 | COMMON STOCK-FO | 6,545,642 | $59,238,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 1,875,209 | $46,880,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 1,884,782 | $41,465,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 2,456,669 | $38,693,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 1,688,412 | $37,128,000 | thousands by filing date | |
| PREVAIL THERAPEUTICS INC | 74140Y101 | COM | 2,743,625 | $36,216,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 1,340,828 | $34,526,000 | thousands by filing date | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 1,119,963 | $32,669,000 | thousands by filing date | |
| KALA BIO INC COM | 483119103 | Stock | 4,537,478 | $28,949,000 | thousands by filing date | |
| SHOCKWAVE MED INC | 82489T104 | COM | 495,608 | $28,294,000 | thousands by filing date | |
| PRECISION BIOSCIENCES INC | 74019P108 | COM | 1,842,366 | $24,411,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 2,689,444 | $21,293,000 | thousands by filing date | |
| ALECTOR INC | 014442107 | COMMON STOCK | 1,000,000 | $19,000,000 | thousands by filing date | |
| G1 THERAPEUTICS INC | 3621LQ109 | COM | 483,990 | $14,839,000 | thousands by filing date | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 861,393 | $12,921,000 | thousands by filing date | |
| SCPHARMACEUTICALS INC | 810648105 | COM | 3,247,005 | $10,358,000 | thousands by filing date | |
| ODONATE THERAPEUTICS INC | 676079106 | COM | 200,000 | $7,338,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-19-040093 | this filing | 2019-08-14 | acceptance time not in the bulk data set |